| Source | Code | Name | Case count | Share of cases (%) |
|---|---|---|---|---|
| PURCH | PURCH_ATC(A10BA02) | Metformin | 44019 | |
| PURCH | PURCH_ATC(A10AE04) | Insulin glargine | 14131 | |
| PURCH | PURCH_ATC(A10BH01) | Sitagliptin | 12783 | |
| PURCH | PURCH_ATC(A10AB05) | Insulin aspart | 10648 | |
| PURCH | PURCH_ATC(A10BB12) | Glimepiride | 9920 | |
| PURCH | PURCH_ATC(A10AE05) | Insulin detemir | 8004 | |
| PURCH | PURCH_ATC(A10AB01) | Insulin (human) | 5670 | |
| PURCH | PURCH_ATC(A10BB01) | Glibenclamide | 5098 | |
| PURCH | PURCH_ATC(A10BD07) | Metformin and sitagliptin | 4924 | |
| PURCH | PURCH_ATC(A10AB04) | Insulin lispro | 4746 | |
| PURCH | PURCH_ATC(A10BH05) | Linagliptin | 4641 | |
| PURCH | PURCH_ATC(A10BX01) | Guar gum | 3474 | |
| PURCH | PURCH_ATC(A10BG03) | Pioglitazone | 2576 | |
| PURCH | PURCH_ATC(A10AE06) | Insulin degludec | 2323 | |
| PURCH | PURCH_ATC(A10BJ02) | Liraglutide | 2242 | |
| PURCH | PURCH_ATC(A10BH02) | Vildagliptin | 2041 | |
| PURCH | PURCH_ATC(A10BD03) | Metformin and rosiglitazone | 1467 | |
| PURCH | PURCH_ATC(A10BG02) | Rosiglitazone | 1419 | |
| PURCH | PURCH_ATC(A10BB07) | Glipizide | 1377 | |
| PURCH | PURCH_ATC(A10BX07) | Liraglutide | 1270 | |
| PURCH | PURCH_ATC(A10AB06) | Brinzolamide | 1125 | |
| PURCH | PURCH_ATC(A10BX02) | Repaglinide | 1093 | |
| PURCH | PURCH_ATC(A10BX04) | Exenatide | 1023 | |
| PURCH | PURCH_ATC(A10BX09) | Dapagliflozin | 837 | |
| PURCH | PURCH_ATC(A10BJ01) | Exenatide | 783 | |
| PURCH | PURCH_ATC(A10BJ06) | Name not found | 749 | |
| PURCH | PURCH_ATC(A10BD08) | Metformin and vildagliptin | 736 | |
| OUTPAT | OUTPAT_ICD10(E139) | Other specified diabetes mellitus, without complications | 641 | |
| PURCH | PURCH_ATC(A10BJ05) | Dulaglutide | 518 | |
| PURCH | PURCH_ATC(A10BD20) | Metformin and empagliflozin | 504 | |
| PURCH | PURCH_ATC(A10BD05) | Metformin and pioglitazone | 411 | |
| PURCH | PURCH_ATC(A10BD15) | Metformin and dapagliflozin | 397 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(E139) | Other specified diabetes mellitus, without complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 307 | |
| INPAT | INPAT_ICD10(E139) | Other specified diabetes mellitus, without complications | 260 | |
| PURCH | PURCH_ATC(A10BD11) | Metformin and linagliptin | 234 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(E13) | Other specified diabetes mellitus. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 180 | |
| PURCH | PURCH_ATC(A10BH03) | Saxagliptin | 163 | |
| PURCH | PURCH_ATC(A10BX12) | Empagliflozin | 111 | |
| OUTPAT | OUTPAT_ICD10(E138) | Other specified diabetes mellitus, with unspecified complications | 85 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(E137) | Other specified diabetes mellitus, with multiple complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 67 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(E138) | Other specified diabetes mellitus, with unspecified complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 65 | |
| OUTPAT | OUTPAT_ICD10(E137) | Other specified diabetes mellitus, with multiple complications | 59 | |
| INPAT | INPAT_ICD10(E138) | Other specified diabetes mellitus, with unspecified complications | 53 | |
| PURCH | PURCH_ATC(A10BX03) | Nateglinide | 52 | |
| PURCH | PURCH_ATC(A10AE01) | Human insulin | 51 | |
| OUTPAT | OUTPAT_ICD10(E131) | Other specified diabetes mellitus, with ketoacidosis | 50 | |
| PURCH | PURCH_ATC(A10BD19) | Linagliptin and empagliflozin | 50 | |
| PURCH | PURCH_ATC(A10BH04) | Alogliptin | 45 | |
| INPAT | INPAT_ICD10(E131) | Other specified diabetes mellitus, with ketoacidosis | 41 | |
| PURCH | PURCH_ATC(A10BD10) | Metformin and saxagliptin | 35 | |
| OUTPAT | OUTPAT_ICD10(E134) | Other specified diabetes mellitus, with neurological complications | 32 | |
| OUTPAT | OUTPAT_ICD10(E133) | Other specified diabetes mellitus, with ophthalmic complications | 26 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(E133) | Other specified diabetes mellitus, with ophthalmic complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 26 | |
| INPAT | INPAT_ICD10(E137) | Other specified diabetes mellitus, with multiple complications | 25 | |
| OUTPAT | OUTPAT_ICD10(E136) | Other specified diabetes mellitus, with other specified complications | 25 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(E136) | Other specified diabetes mellitus, with other specified complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 20 | |
| OUTPAT | OUTPAT_ICD10(E130) | Other specified diabetes mellitus, with coma | 18 | |
| INPAT | INPAT_ICD10(E130) | Other specified diabetes mellitus, with coma | 17 | |
| OUTPAT | OUTPAT_ICD10(E132) | Other specified diabetes mellitus, with renal complications | 17 | |
| OUTPAT | OUTPAT_ICD10(E135) | Other specified diabetes mellitus, with peripheral circulatory complications | 16 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(E134) | Other specified diabetes mellitus, with neurological complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 16 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(E132) | Other specified diabetes mellitus, with renal complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 15 | |
| INPAT | INPAT_ICD10(E136) | Other specified diabetes mellitus, with other specified complications | 13 | |
| OUTPAT | OUTPAT_ICD10(E13) | Other specified diabetes mellitus | 13 | |
| PURCH | PURCH_ATC(A10BD09) | Pioglitazone and alogliptin | 13 | |
| PURCH | PURCH_ATC(A10BJ03) | Lixisenatide | 13 | |
| PURCH | PURCH_ATC(A10BD13) | Metformin and alogliptin | 12 | |
| INPAT | INPAT_ICD10(E134) | Other specified diabetes mellitus, with neurological complications | 11 | |
| PURCH | PURCH_ATC(A10BD21) | Saxagliptin and dapagliflozin | 11 | |
| INPAT | INPAT_ICD10(E132) | Other specified diabetes mellitus, with renal complications | 10 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(E131) | Other specified diabetes mellitus, with ketoacidosis. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 9 | |
| INPAT | INPAT_ICD10(E133) | Other specified diabetes mellitus, with ophthalmic complications | 8 | |
| INPAT | INPAT_ICD10(E135) | Other specified diabetes mellitus, with peripheral circulatory complications | 8 | |
| DEATH | DEATH_ICD10(E139) | Other specified diabetes mellitus, without complications | 7 | |
| PURCH | PURCH_ATC(A10BB02) | Chlorpropamide | 7 | |
| PURCH | PURCH_ATC(A10BX10) | Lixisenatid | 7 | |
| DEATH | DEATH_ICD10(E131) | Other specified diabetes mellitus, with ketoacidosis | 6 | |
| INPAT | INPAT_ICD10(E13) | Other specified diabetes mellitus | 6 | |
| DEATH | DEATH_ICD10(E138) | Other specified diabetes mellitus, with unspecified complications | 5 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(E135) | Other specified diabetes mellitus, with peripheral circulatory complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 5 |